HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Jason Abel Selected Research

E Jason Abel Research Topics

Disease

38Neoplasms (Cancer)
08/2022 - 07/2010
24Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 07/2010
9Prostatic Neoplasms (Prostate Cancer)
01/2021 - 05/2008
6Thrombosis (Thrombus)
01/2020 - 06/2011
6Neoplasm Metastasis (Metastasis)
01/2019 - 07/2010
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 12/2014
3Necrosis
09/2021 - 10/2014
2Lymphadenopathy
01/2020 - 07/2010
2Carcinoma (Carcinomatosis)
01/2020 - 11/2013
2Pain (Aches)
01/2020 - 11/2017
2Kidney Neoplasms (Kidney Cancer)
01/2019 - 10/2014
2Morbid Obesity
10/2016 - 01/2016
2Venous Thrombosis (Deep-Vein Thrombosis)
07/2015 - 04/2014
2Pulmonary Embolism
07/2015 - 04/2014
2Obesity
07/2015 - 11/2013
1Pathologic Constriction (Stenosis)
09/2021
1Solitary Kidney
08/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2019
1Diabetes Mellitus
12/2018
1Type 2 Diabetes Mellitus (MODY)
12/2018
1Disease Progression
01/2018
1Hemorrhage
11/2017
1Inflammation (Inflammations)
04/2017
1Lymphatic Metastasis
01/2017
1Carcinoma in Situ
11/2015
1Venous Thromboembolism
07/2015
1Hypoxia (Hypoxemia)
05/2014
1Testicular Neoplasms (Testicular Cancer)
10/2012
1Vesico-Ureteral Reflux (Vesicoureteral Reflux)
04/2010

Drug/Important Bio-Agent (IBA)

6AndrogensIBA
01/2021 - 01/2017
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020 - 07/2010
3Sunitinib (Sutent)FDA Link
12/2011 - 04/2011
2Hemoglobins (Hemoglobin)IBA
01/2020 - 10/2017
2Biomarkers (Surrogate Marker)IBA
01/2019 - 05/2014
2Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2014
2C-Reactive ProteinIBA
01/2019 - 05/2014
2Indicators and Reagents (Reagents)IBA
04/2017 - 11/2016
1cabozantinibIBA
01/2022
1SteamIBA
09/2021
1Fibroblast Growth Factor 1 (FGF-1)IBA
01/2021
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
01/2021
1N 30IBA
01/2021
1Adrenergic Agents (Adrenergic Drugs)IBA
09/2020
1Antihypertensive Agents (Antihypertensives)IBA
09/2020
1Complement System Proteins (Complement)IBA
05/2019
1CollagenIBA
05/2019
1Angiogenesis InhibitorsIBA
04/2019
1Pharmaceutical PreparationsIBA
04/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019
1Agent OrangeIBA
01/2019
1Metformin (Glucophage)FDA LinkGeneric
12/2018
1Androgen Receptors (Androgen Receptor)IBA
01/2018
1Hormones (Hormone)IBA
01/2018
1Celecoxib (Celebrex)FDA Link
01/2018
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2018
1AnticoagulantsIBA
11/2017
1Anti-Bacterial Agents (Antibiotics)IBA
11/2017
1AntibodiesIBA
11/2016
1Platelet Endothelial Cell Adhesion Molecule-1IBA
11/2016
1EndoglinIBA
11/2016
1Factor V (Coagulation Factor V)IBA
07/2016
1Axitinib (AG 013736)IBA
04/2016
1ReninIBA
11/2015
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2015
1AngiotensinsIBA
11/2015
1Angiotensin Receptor AntagonistsIBA
11/2015
1Heparin (Liquaemin)FDA LinkGeneric
07/2015
1Alkaline PhosphataseIBA
10/2014
1Carbonic Anhydrase IXIBA
05/2014
1Prostate-Specific Antigen (Semenogelase)IBA
11/2013
1LuciferasesIBA
04/2011
1EverolimusFDA Link
04/2011
1AlbuminsIBA
07/2010
1dextranomerIBA
04/2010
1defluxIBA
04/2010

Therapy/Procedure

15Nephrectomy
09/2021 - 07/2010
14Therapeutics
01/2022 - 05/2008
4Prostatectomy (Retropubic Prostatectomy)
04/2019 - 06/2009
3Cryosurgery
08/2022 - 09/2014
3Cystectomy
01/2020 - 12/2014
3Blood Transfusion (Blood Transfusions)
01/2016 - 05/2013
2Lymph Node Excision (Lymph Node Dissection)
01/2018 - 01/2017
2Transurethral Resection of Bladder
04/2017 - 11/2015
2Patient Readmission
10/2016 - 01/2016
1Radiotherapy
10/2021
1Punctures
09/2021
1Lab-On-A-Chip Devices
11/2020
1Vascular Access Devices (Arterial Line)
09/2020
1Epidural Anesthesia
01/2020
1Skin Transplantation (Skin Grafting)
01/2020
1Anesthesia
01/2020
1Aftercare (After-Treatment)
08/2019
1Cytoreduction Surgical Procedures
01/2019
1Thrombectomy
05/2018
1Radiofrequency Ablation
09/2014
1Operative Time
04/2014
1Nephroureterectomy
11/2013
1Drug Therapy (Chemotherapy)
10/2012
1Adrenalectomy
08/2011
1Molecular Targeted Therapy
06/2011